These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 21166497

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
    Basile A, Moschetta M, Ditonno P, Ria R, Marech I, De Luisi A, Berardi S, Frassanito MA, Angelucci E, Derudas D, Specchia G, Curci P, Pavone V, Rossini B, Ribatti D, Bottazzi B, Mantovani A, Presta M, Dammacco F, Vacca A.
    J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M, Muragaki Y, Ooshima A.
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, Milia AF, Bellando-Randone S, Fiori G, Conforti ML, Saccardi R, Ibba-Manneschi L, Matucci-Cerinic M.
    Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
    [Abstract] [Full Text] [Related]

  • 9. High efficient adenoviral-mediated VEGF and Ang-1 gene delivery into osteogenically differentiated human mesenchymal stem cells.
    Klöpper J, Lindenmaier W, Fiedler U, Mehlhorn A, Stark GB, Finkenzeller G.
    Microvasc Res; 2008 Jan; 75(1):83-90. PubMed ID: 17603084
    [Abstract] [Full Text] [Related]

  • 10. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H, Wierzbowska A, Robak T.
    Eur Cytokine Netw; 2003 Jan; 14(1):40-51. PubMed ID: 12799213
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
    Kaga T, Kawano H, Sakaguchi M, Nakazawa T, Taniyama Y, Morishita R.
    Vascul Pharmacol; 2012 Aug 19; 57(1):3-9. PubMed ID: 22361334
    [Abstract] [Full Text] [Related]

  • 13. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.
    Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ.
    Stem Cells; 2007 Sep 19; 25(9):2363-70. PubMed ID: 17540857
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation.
    Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, Weich H.
    J Cell Biochem; 2005 Jul 01; 95(4):827-39. PubMed ID: 15838884
    [Abstract] [Full Text] [Related]

  • 16. Angiogenesis in multiple myeloma.
    Jakob C, Sterz J, Zavrski I, Heider U, Kleeberg L, Fleissner C, Kaiser M, Sezer O.
    Eur J Cancer; 2006 Jul 01; 42(11):1581-90. PubMed ID: 16797965
    [Abstract] [Full Text] [Related]

  • 17. A potential role for islet-1 in post-natal angiogenesis and vasculogenesis.
    Barzelay A, Ben-Shoshan J, Entin-Meer M, Maysel-Auslender S, Afek A, Barshack I, Keren G, George J.
    Thromb Haemost; 2010 Jan 01; 103(1):188-97. PubMed ID: 20062933
    [Abstract] [Full Text] [Related]

  • 18. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
    Roccaro AM, Hideshima T, Raje N, Kumar S, Ishitsuka K, Yasui H, Shiraishi N, Ribatti D, Nico B, Vacca A, Dammacco F, Richardson PG, Anderson KC.
    Cancer Res; 2006 Jan 01; 66(1):184-91. PubMed ID: 16397231
    [Abstract] [Full Text] [Related]

  • 19. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
    Tanaka Y, Abe M, Hiasa M, Oda A, Amou H, Nakano A, Takeuchi K, Kitazoe K, Kido S, Inoue D, Moriyama K, Hashimoto T, Ozaki S, Matsumoto T.
    Clin Cancer Res; 2007 Feb 01; 13(3):816-23. PubMed ID: 17289872
    [Abstract] [Full Text] [Related]

  • 20. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets in vitro.
    Kanayama S, Nishida K, Yamato M, Hayashi R, Sugiyama H, Soma T, Maeda N, Okano T, Tano Y.
    Exp Eye Res; 2007 Dec 01; 85(6):772-81. PubMed ID: 17904552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.